AJP - Heart Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 289: H2665-H2672, 2005. First published July 29, 2005; doi:10.1152/ajpheart.00682.2005
0363-6135/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/H2665    most recent
00682.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, Y.-C.
Right arrow Articles by Chaudry, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, Y.-C.
Right arrow Articles by Chaudry, I. H.

PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage

Ya-Ching Hsieh, Shaolong Yang, Mashkoor A. Choudhry, Huang-Ping Yu, Loring W. Rue, III, Kirby I. Bland, and Irshad H. Chaudry

Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama

Submitted 23 June 2005 ; accepted in final form 26 July 2005


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Flutamide, an androgen receptor antagonist, is thought to improve cardiovascular function by blocking the androgen receptor after trauma-hemorrhage (T-H). Although 17{beta}-estradiol (E2) and flutamide improve cardiac function after T-H, whether E2 and flutamide produce their salutary effect via the same or a different mechanism is unknown. We hypothesized that E2 and flutamide mediate their effects via estrogen receptor (ER)-mediated upregulation of peroxisome proliferator-activated receptor coactivator 1 (PGC-1). PGC-1, a key regulator of cardiac mitochondrial function, induces mitochondrial genes by activating transcription factors such as nuclear respiratory factor 2 (NRF-2), which regulates mitochondrial proteins [i.e., mitochondrial transcription factor A (Tfam), cytochrome-c oxidase subunit IV, and {beta}-ATP synthase]. Adult male rats underwent T-H [5-cm midline incision and hemorrhage (blood pressure = 40 mmHg for ~90 min)] and resuscitation. At the onset of resuscitation, rats received vehicle, flutamide (25 mg/kg), or E2 (50 µg/kg). Another group received the ER antagonist ICI-182780 (3 mg/kg) with or without flutamide. Flutamide or E2 administration after T-H restored depressed cardiac function. Moreover, E2 and flutamide normalized expression of cardiac PGC-1, NRF-2, Tfam, cytochrome-c oxidase subunit IV, and the mitochondrial DNA-encoded gene cytochrome-c oxidase subunit I and {beta}-ATP synthase, mitochondrial ATP, and cytochrome-c oxidase activity. However, if the ER antagonist ICI-182780 was administered with flutamide, flutamide-mediated PGC-1 upregulation was totally abolished. These results indicate that E2 and flutamide upregulate PGC-1 via the ER. Thus PGC-1 upregulation appears to be the common mechanism by which E2 and flutamide mediate their salutary effects on cardiac function after T-H.

hemorrhagic shock; adenosine triphosphate; sex hormones; androgen receptors; adenosinetriphosphatase

DESPITE NUMEROUS ADVANCES in intensive care medicine, sepsis, organ dysfunction, and ischemia-reperfusion injury remain the major causes of death in trauma patients as well as in patients after major surgery (5, 12, 13, 16, 32, 38). Previous studies have shown prolonged depression of cardiovascular function in male rats after trauma-hemorrhagic shock, despite fluid resuscitation (2, 24). However, depletion of androgen levels by castration in male rats 2 wk before trauma-hemorrhage prevented the depression in cardiac function after trauma-hemorrhage (2, 23, 34). Alternatively, administration of the androgen receptor antagonist flutamide to intact male rats after trauma-hemorrhage prevented the depression of cardiac function (24). Moreover, administration of 17{beta}-estradiol (E2) to male or ovariectomized female animals after trauma-hemorrhage restored depressed cardiovascular function (10, 11, 18). These studies therefore indicate that male and female sex steroids differentially influence cardiovascular function after trauma-hemorrhage. Although studies have also shown that inflammatory cytokines, inducible nitric oxide synthase, or signal transducer and activator of transcription 3 (26, 34) play a role in E2- as well as flutamide-mediated beneficial effects on organ function after trauma-hemorrhage, whether E2 and flutamide mediate their salutary effects via the same or different mechanisms remains unknown.

It is well known that mitochondria are abundant in the heart and play a critical role in the regulation of cardiac function, including ATP production. There is also evidence that trauma-hemorrhage decreases tissue ATP stores (4, 21), and in this regard, previous studies have shown that estrogens can prevent depletion of tissue ATP (30). Conversely, androgens have been shown to decrease the activities of mitochondrial complexes I, II, and IV and tissue ATP levels (25). In addition, the nuclear coactivator peroxisome proliferator-activated receptor-{gamma} coactivator 1 (PGC-1), which is highly expressed in heart and skeletal muscle, has been characterized as a broad regulator of cellular energy metabolism and a key regulator of mitochondrial biogenesis (14, 22). PGC-1 induces mitochondrial biogenesis by activating the transcription factor nuclear respiratory factor (NRF) 2, which regulates expression of mitochondrial proteins. NRF-2 in turn transactivates expression of nuclear genes required for mitochondrial function, including nuclear-encoded mitochondrial transcription factor A (Tfam), cytochrome-c oxidase subunit IV (COX IV) enzyme, and {beta}-ATP synthase (6, 27, 28, 33). Because E2 and flutamide improved cardiac function after trauma-hemorrhage, we hypothesized that E2 and flutamide mediate their beneficial effects by upregulating PGC-1-controlled mitochondrial biogenesis and ATP production in the heart after trauma-hemorrhage. To test this hypothesis, we examined the effects of E2 and flutamide after trauma-hemorrhage on 1) cardiac function, 2) cardiac PGC-1 protein levels, 3) cardiac mitochondrial ATP levels, cytochrome-c oxidase activity, and mitochondrial DNA-encoded gene cytochrome-c oxidase subunit I (COX I) expression, 4) cardiac NRF-2 mRNA expression, and 5) cardiac Tfam, COX IV, and {beta}-ATP synthase mRNA expression and mitochondrial protein levels.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Rat trauma-hemorrhagic shock model. Male Sprague-Dawley rats (Charles River) were fasted overnight but allowed free access to water before the experiments. Trauma-hemorrhage and resuscitation were then carried out as described previously (2, 11, 23, 24, 34). Briefly, the rats were anesthetized by isoflurane inhalation, and a 5-cm midline laparotomy was performed to induce soft tissue trauma. The abdominal wound was closed in layers, and polyethylene catheters (PE-50, Becton Dickinson, Sparks, MD) were placed in both femoral arteries and the right femoral vein. The rats were allowed to awaken and then bled rapidly within 10 min to a mean arterial pressure (MAP) of 35–40 mmHg. This hypotension was maintained until the animals could no longer maintain 35 mmHg MAP without administration of fluid in the form of Ringer lactate solution. This time was defined as maximal bleed out (MBO). After MBO, MAP was maintained at 35–40 mmHg until 40% of MBO volume was returned in the form of Ringer lactate solution (~90 min from the onset of bleeding). The rats were then resuscitated with four times the volume of MBO with Ringer lactate over 60 min. After resuscitation, the catheters were removed and the wounds were closed. Sham-operated animals underwent surgical procedures without hemorrhage or resuscitation. The animals were killed 2 h after the end of resuscitation or sham operation. In the treatment group, E2 (50 µg/kg body wt) or flutamide (25 mg/kg body wt; Sigma, St. Louis, MO) was administered subcutaneously at the beginning of resuscitation. In another group of rats, ICI-182780 (3 mg/kg body wt ip; Tocris Cookson, Ellisville, MO) was administered with or without flutamide. Rats in the vehicle-treated group received the same volume of vehicle (corn oil or 1,2-propanediol, 1 ml/kg body wt sc; Sigma). Five to seven animals were studied in each group. This study was approved by our Institutional Animal Care and Use Committee at the University of Alabama at Birmingham.

Determination of cardiac function. At 2 h after trauma-hemorrhage or sham operation, the animals were anesthetized with pentobarbital sodium (30–50 mg/kg ip). Cardiac output (CO) was determined by using the indocyanine green (ICG) dilution technique (8). A 2.4-Fr fiber-optic catheter (Hospex Fiberoptics, Chestnut Hill, MA) was inserted to the level of the aortic arch for continuous measurement of ICG concentration via an in vivo hemoreflectometer (Schwarzer-Picker International, Munich, Germany). A silicone rubber catheter was inserted to the level of the right atrium. ICG (50 µl, 1 mg/ml) was injected via the right jugular vein catheter. The concentration of ICG was recorded by using a computer-assisted data acquisition program (Asystant+, Asyst Software, Rochester, NY). After the measurement of CO, the right carotid artery was recannulated with PE-50 tubing, and after the measurement of blood pressure, the catheter was advanced into the left ventricle and connected to a heart performance analyzer (DigiMed) to monitor and record positive and negative first derivatives of pressure (+dP/dtmax and –dP/dtmax). CO, stroke volume (SV), and total peripheral resistance (TPR) were calculated according to standard equations.

Isolation of mitochondria. After the animals were euthanized, the hearts were removed, minced, and then homogenized gently with a motor-driven grinder in 0.25 M sucrose, 0.5 mM EGTA, and 3 mM HEPES, pH 7.2, at 10 ml/g of heart. The suspension was centrifuged at 750 g for 10 min at 4°C. The supernatant was centrifuged twice at 9,500 g for 10 min, and the pellet fraction-enriched mitochondria were collected and stored at –70°C for measurements of ATP levels and cytochrome-c oxidase activity.

Cytochrome c oxidase assays. The cytochrome-c oxidase activity of cardiac mitochondria was analyzed by an assay kit (Sigma) according to the manufacturer's instructions. Briefly, isolated mitochondria were homogenized in assay buffer (10 mM Tris·HCl, pH 7.0, and 120 mM KCl). Approximately 500 µg of mitochondrial protein were added to 1.1 ml of reaction solution containing 50 µl of 0.22 mM fully reduced ferrocytochrome c, 10 mM Tris·HCl (pH 7.0), and 120 mM KCl. The decrease of absorbance at 550 nm was recorded over a 1-min reaction time.

Determination of mitochondrial ATP levels. ATP content was measured by the ATP Bioluminescence Assay kit (Roche, Mannheim, Germany) according to the manufacturer's protocol. Briefly, the mitochondrial pellet was suspended in the lysis reagent supplied in the kit. The suspensions were pipetted and vortexed, and the protein concentrations were measured (Bio-Rad Laboratories, Hercules, CA). The samples were kept on ice until measurements were performed. For determination of ATP, 100 µl of luciferase reagent were added to the standards or 1 mg of mitochondrial proteins, and ATP was measured with a luminometer (AutoLumat LB953, Berthold, Wildbad, Germany).

Quantitative real-time PCR. Total RNA was prepared in TriReagent (Life Technologies, Grand Island, NY), and 2 µg of total RNA were reversed to cDNA by Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI). Real-time PCR was performed using SYBR green or TaqMan methods on a sequence detection system (PRISM 7900 HT, Applied Biosystems, Foster City, CA). The sequences of primers and probes used in this study were designed using the Prism Primer Express Program (Applied Biosystems): 5'-aggtgacgagatgggctgc-3' and 5'-cgttgtccccatttttgcg-3' for NRF-2, 5'-gaaagcacaaatcaagaggag-3' and 5'-ctgcttttcatcatgagacag-3' for Tfam, 5'-tgggagtgttgtgaagagtga-3' and 5'-gcagtgaagccgatgaagaac-3' for COX IV, 5'-agccactgacatgggtacaatg-3', 5'-tcatcagctggcacatagatagc-3', and 5'-accaagaagggctcgat-3' (probe) for {beta}-ATP synthase, and 5'-agtattcgccatcatagcttgct-3', 5'-gcttttgctcatgtgtcatttagg-3', and 5'-tcccactattctcaggcta (probe) for COX I. The reaction mixture for TaqMan assay contained 5 µl of 2x TaqMan Universal PCR Master Mix (Applied Biosystems), 0.2 µmol/l {beta}-ATP synthase and COX I primers, 0.25 µmol/l {beta}-ATP synthase and COX I TaqMan probes, and 40 ng of cDNA. The reaction mixture for SYBR green assay contained 10 µl of 2x SYBR green PCR Master Mix (Applied Biosystems), 0.5 µmol/l (NRF-2), 0.3 µmol/l (COX IV), or 0.4 µmol/l (Tfam) primers, and 40 ng of cDNA. All samples were tested in triplicate, and average values were used for quantification. 18S rRNA was used as an endogenous control. At each cycle, accumulation of PCR products was detected by monitoring the increase in fluorescence of the reporter dye from the TaqMan probes or double-stranded DNA-binding SYBR green. Analysis was performed by using SDS version 2.2 software (Applied Biosystems) according to the manufacturer's instructions. The comparative cycle threshold (CT) method ({Delta}{Delta}CT) was used for quantification of gene expression.

Western blot analysis. For PGC-1 protein detection, heart tissues were homogenized in lysis buffer consisting of 150 mM NaCl, 1 mM EDTA, 2 mM Na2P2O6, 30 mM NaF, 20 mM Tris·HCl, pH 7.5, 1% Triton X-100, 0.1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, and 10 µg/ml aprotinin. Tissue lysates were centrifuged at 17,000 g for 10 min. For detection of Tfam, COX IV, and {beta}-ATP synthase protein, mitochondrial pellets were suspended in 0.25 M sucrose, 0.5 mM EGTA, and 3 mM HEPES, pH 7.2. The protein concentrations were measured and separated by SDS-PAGE and transferred to nitrocellulose paper. After the membranes were immunoblotted with anti-PGC-1, Tfam (Santa Cruz Biotechnology, Santa Cruz, CA), COX IV (Molecular Probes, Eugene, OR), {beta}-ATP synthase, GAPDH, and {beta}-actin (Abcam, Cambridge, MA) antibody, horseradish peroxidase-conjugated secondary antibody was added. After the final wash, membranes were probed by using enhanced chemiluminescence (Amersham, Piscataway, NJ) and subjected to autoradiography. GAPDH and {beta}-actin were used as loading controls.

Statistical analysis. Values are means ± SE. One-way ANOVA and Tukey's test were employed for comparison among groups, and differences were considered significant at P < 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Effect of flutamide or E2 on cardiac function. CO, SV, +dP/dtmax, and –dP/dtmax decreased (P < 0.05 for all parameters) in the vehicle-treated trauma-hemorrhage group compared with the sham-operated group (Fig. 1). In contrast, TPR increased (P < 0.05) under these conditions (Fig. 1C). Flutamide or E2 administration after trauma-hemorrhage, however, restored these cardiac parameters to levels similar to those in the sham-operated group (Fig. 1). Our previous studies showed no significant difference in cardiac function between nontreated sham-operated animals and E2- or flutamide-treated sham-operated animals; hence, the effects of E2 and flutamide on cardiac function in sham-operated rats were not examined in this study (18, 36).



View larger version (33K):
[in this window]
[in a new window]
  		Fig. 1. Effects of flutamide (FL) and 17{beta}-estradiol (E2) on cardiac output (CO), stroke volume (SV), total peripheral resistance (TPR), and positive and negative 1st derivatives of pressure (+dP/dtmax and –dP/dtmax) after sham operation (S) and trauma-hemorrhage (T-H). Values are means ± SE of 6 animals in each group. Results were compared by 1-way ANOVA and Tukey's test. T-H group was treated with vehicle (Veh), E2, and FL. BW, body weight. *P < 0.05 vs. S, T-H E2, and T-H FL.

 
Effect of flutamide or E2 on cardiac PGC-1 protein levels. To determine the possible mechanisms of flutamide and E2 on cardiac mitochondrial function, PGC-1, a key regulator of mitochondrial biogenesis, was determined by Western blotting. Cardiac PGC-1 protein increased after trauma-hemorrhage in the vehicle-treated group compared with the sham-operated group (Fig. 2; P < 0.05). However, administration of flutamide or E2 after trauma-hemorrhage prevented the decrease in PGC-1 protein under those conditions. Although flutamide as well as E2 administration to sham-operated animals increased PGC-1 protein levels by 20%, the increase was not statistically significant by ANOVA.



View larger version (35K):
[in this window]
[in a new window]
  		Fig. 2. Effects of FL and E2 on protein levels of peroxisome proliferator-activated receptor-{gamma} coactivator 1 (PGC-1) in heart after S and T-H. GAPDH was used as a loading control. Blots obtained from several experiments were analyzed by using densitometry, and densitometric values were pooled from 7 animals in each group. Values are means ± SE. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2, and T-H FL.

 
Effect of flutamide or E2 on cardiac mitochondrial ATP levels, cytochrome-c oxidase activity, and mitochondrial DNA-encoded COX I gene. To evaluate the PGC-1 downstream effects, we measured mitochondrial ATP levels, cytochrome-c oxidase activity, and mitochondrial DNA-encoded COX I gene expression. Cardiac mitochondrial ATP levels (Fig. 3), cytochrome-c oxidase activity (Fig. 4), and mitochondrial DNA-encoded COX I gene expression (Fig. 5) decreased in the vehicle-treated trauma-hemorrhage group compared with the sham-operated group (P < 0.05). Flutamide or E2 administration after trauma-hemorrhage, however, increased mitochondrial ATP levels, cytochrome-c oxidase activity and mitochondrial DNA-encoded COX I gene expression similar to levels in the sham-operated animals.



View larger version (19K):
[in this window]
[in a new window]
  		Fig. 3. Effects of FL and E2 on ATP contents of cardiac mitochondria after S and T-H. Values are means ± SE of 6 animals in each group. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2, and T-H FL.

 


View larger version (22K):
[in this window]
[in a new window]
  		Fig. 4. Effects of FL and E2 on cytochrome-c oxidase activity of cardiac mitochondria after S and T-H. Values are means ± SE of 5–6 animals in each group. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2, and T-H FL.

 


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 5. Effects of FL and E2 on mitochondrial DNA-encoded cytochrome-c oxidase subunit I (COX I) in heart after S and T-H. Values are means ± SE of 5–6 animals in each group. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2, and T-H FL.

 
Effect of flutamide or E2 on cardiac NRF-2 mRNA expression. Because NRF-2 mRNA expression can be induced by PGC-1, NRF-2 mRNA expression was determined by real-time PCR after trauma-hemorrhage. Cardiac NRF-2 mRNA expression decreased significantly in the vehicle-treated trauma-hemorrhage group (P < 0.05; Fig. 6) but increased with administration of flutamide or E2 and was similar to that in the sham-operated animals.



View larger version (18K):
[in this window]
[in a new window]
  		Fig. 6. Effects of FL and E2 on mRNA expressions of nuclear respiratory factor (NRF)-2 in heart after S and T-H. Values are means ± SE of 5 animals in each group. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2, and T-H FL.

 
Effect of flutamide or E2 on cardiac Tfam, COX IV, and {beta}-ATP synthase mRNA expression and protein levels. NRF-2 transactivates the regulators of mitochondrial function, including Tfam, COX IV, and {beta}-ATP synthase. Accordingly, mRNA expression was determined by real-time PCR, and protein levels were measured by Western blot. Cardiac Tfam, COX IV, and {beta}-ATP synthase mRNA expression (Fig. 7) and cardiac mitochondrial Tfam, COX IV, and {beta}-ATP protein levels (Fig. 8) decreased significantly in the vehicle-treated trauma-hemorrhage group compared with the sham-operated group (P < 0.05). Cardiac Tfam, COX IV, and {beta}-ATP synthase mRNA expression and cardiac mitochondrial Tfam, COX IV, and {beta}-ATP synthase protein levels were increased in trauma-hemorrhage rats treated with flutamide or E2 and similar to those in the sham-operated animals.



View larger version (21K):
[in this window]
[in a new window]
  		Fig. 7. Effects of FL and E2 on mRNA expressions of mitochondrial transcription factor A (Tfam), COX IV, and {beta}-ATP synthase in heart after S and T-H. Values are means ± SE of 5 animals in each group. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2,and T-H FL.

 


View larger version (28K):
[in this window]
[in a new window]
  		Fig. 8. Effects of FL and E2 on protein levels of Tfam, COX IV, and {beta}-ATP synthase in heart after S and T-H. Protein expression blots from several experiments were analyzed by using densitometry, and densitometric values were pooled from 6 animals in each group. Values are means ± SE. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S, T-H E2, and T-H FL.

 
Effect of the estrogen receptor antagonist ICI-182780 alone or in combination with flutamide on cardiac PGC-1. To evaluate whether flutamide mediated the upregulation of PGC-1 via the estrogen receptor (ER), rats subjected to trauma-hemorrhage were treated with the ER antagonist ICI-182780 alone or in combination with flutamide. PGC-1 protein levels were significantly decreased in the trauma-hemorrhage group treated with vehicle or ICI-182780 alone (Fig. 9). The decrease in PGC-1 after trauma-hemorrhage was, however, not evident in rats treated with flutamide after trauma-hemorrhage. The flutamide-mediated upregulation of PGC-1 was, however, prevented in the trauma-hemorrhage rats treated with ICI-182780 in combination with flutamide (Fig. 9; P < 0.05).



View larger version (31K):
[in this window]
[in a new window]
  		Fig. 9. Effects of ICI-182780 (ICI) alone and in combination with FL on protein levels of PGC-1 in heart after S and T-H. Blots from several experiments were analyzed by using densitometry, and densitometric values were pooled from 5–6 animals in each group. Values are means ± SE. Data were compared by 1-way ANOVA and Tukey's test. *P < 0.05 vs. S and T-H FL.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
Previous studies have shown that CO is depressed in male rats after trauma-hemorrhage but is maintained in proestrous female rats (10, 11, 23, 24). It has also been shown that administration of E2 or flutamide improves cardiovascular function in male rats after trauma-hemorrhage (11, 18, 24). Furthermore, it has been reported that the salutary effects of E2 are mediated via the ER, because use of ICI-182780 along with E2 blocked the salutary effects of E2 (11). Although it is known that flutamide and E2 improve cardiovascular function after trauma-hemorrhage, the precise mechanism by which E2 and flutamide produce their salutary effects remains unknown. More specifically, whether E2 and flutamide mediate their salutary effects via the same or different mechanisms is unknown. The novelty of this study is that our results clearly indicate that the salutary effects of flutamide are also mediated via the ER, because ICI-182780 blocked the effects of flutamide on PGC-1. Furthermore, we have shown an association between PGC-1 and the mitochondrial pathway in the normalization of cardiac performance with flutamide as well as E2 after trauma-hemorrhage.

The main findings of this study suggest that cardiac function, cardiac PGC-1 protein levels, mitochondrial ATP levels, cytochrome-c oxidase activity, expression of the mitochondrial DNA-encoded COX I gene, and cardiac NRF-2, Tfam, COX IV, and {beta}-ATP synthase mRNA and protein levels in the mitochondrial fraction were markedly decreased 2 h after trauma-hemorrhage. Administration of E2 or flutamide after trauma-hemorrhage normalized cardiac function and increased PGC-1, mitochondrial ATP, cytochrome-c oxidase, mitochondrial DNA-encoded COX I gene, NRF-2, Tfam, COX IV, and {beta}-ATP synthase levels. However, administration of the ER antagonist ICI-182780 along with flutamide after trauma-hemorrhage prevented flutamide-mediated PGC-1 upregulation. These findings therefore suggest that, similar to the effect of E2, the effect of flutamide is mediated via ER-dependent PGC-1 upregulation. Because PGC-1 plays an important role in regulation of NRF-2, Tfam, COX IV, and {beta}-ATP synthase and production of mitochondrial ATP, cytochrome-c oxidase activity, and the mitochondrial DNA-encoded gene COX I, it is likely that upregulation of PGC-1 in trauma-hemorrhage rats treated with E2 and flutamide restores ATP production and thereby prevents alterations in cardiac function after trauma-hemorrhage. Although administration of E2 or flutamide to sham-operated animals increased PGC-1 protein levels by 20%, the increase was not statistically significant. Nonetheless, because administration of flutamide as well as E2 increased PGC-1 protein levels by 20%, it is possible that these two distinct agents upregulated PGC-1 expression through ER and that this effect is independent of trauma-hemorrhage. Moreover, the 20% increase in PGC-1 protein levels in E2- or flutamide-treated sham-operated rats suggests that E2 or flutamide upregulated PGC-1 expression through ER independent of trauma-hemorrhage. These results therefore collectively suggest that upregulation of PGC-1 is the common event through which E2 and flutamide mediate their beneficial effects on cardiac function after trauma-hemorrhage. However, although ICI-182780 blocked the flutamide-induced upregulation of PGC-1, indicating that the effects of flutamide are mediated via PGC-1, blockade of PGC-1 upregulation by agents other than ICI-182780 should provide additional proof that PGC-1 plays a pivotal role in the salutary effects of flutamide and estrogen on cardiac function after trauma-hemorrhage. However, because specific blockers of PGC-1 are not available, it is difficult to perform such a study.

Gender differences exist in the cardiovascular diseases (17). Our previous studies have also shown that male sex hormones have deleterious effects and female sex hormones produce beneficial effects on cardiovascular function after trauma-hemorrhage (3, 10, 29). In this study, E2 or flutamide treatment at the beginning of resuscitation restored all parameters of cardiac function, including CO, SV, TPR, +dP/dtmax, and –dP/dtmax 2 h after trauma-hemorrhage. These findings further corroborate our previous studies and suggest that E2 or flutamide treatment prevented the depression in cardiac function 2, 20, and 24 h after trauma-hemorrhage (18, 24, 34).

Several potential mechanisms have been proposed for the salutary effects of E2 and flutamide on organ function after trauma-hemorrhage. A recent study by Yang et al. (34) suggested that the beneficial effect of E2 on cardiac function may be due in part to attenuation of IL-6 production after trauma-hemorrhage. Studies have also indicated that flutamide administration inhibits thromboxane A2 production and/or enhances release of the vasodilator prostacyclin in the aortic-coronary circulation, leading to improved organ perfusion (24). Additional studies have shown that flutamide decreases cytokine release by macrophages and, thus, improves the depressed immune functions after trauma-hemorrhage (31). Although a potential role of inflammatory cytokines or other mediators in the beneficial effects of E2 and flutamide has not been ruled out, our findings suggest that E2 and flutamide mediate their effects via E2 receptors that upregulate PGC-1, which is critical for cardiac mitochondrial function.

Studies have suggested that the mitochondrion occupies a pivotal position in the physiological response to trauma and shock (9). Previous studies have shown that trauma-hemorrhage impairs mitochondrial oxidative phosphorylation and reduces energy production (15). In addition, it has been suggested that sex steroids play a role in mitochondrial function and ATP production. E2 was shown to protect against ATP depletion, mitochondrial membrane potential decline, and generation of reactive oxygen species induced by 3-nitroproprionic acid (30). E2 also preserves mitochondrial structure and function in the heart during ischemia-reperfusion (37). Because ER-{beta} is present on mitochondria, it is likely that the effect of estrogen was mediated via ER-{beta} (35). In contrast, physiological concentrations of testosterone were able to inhibit maintenance of the proton gradient across the mitochondrial membranes, as well as ATP synthesis, and synthetic androgen exposure lowered the activities of mitochondrial complexes I, II, and IV and ATP levels (7, 25). Thus it is possible that estrogen and anti-androgen can protect mitochondrial function. Among the consequences of mitochondrial depression/dysfunction, loss of ATP production is clearly the most profound, especially in the heart, a tissue specialized for high-capacity ATP production. The results presented here indicate that cardiac mitochondrial ATP levels decreased significantly 2 h after trauma-hemorrhage; however, E2 or flutamide restored cardiac mitochondrial ATP levels. It is likely that the increased/restored mitochondrial ATP levels by E2 or flutamide treatment after trauma-hemorrhage help in the maintenance of myocardial energy and restoration of cardiac function.

The transcriptional coactivator PGC-1, a key regulator of cardiac mitochondrial functional capacity, participates in the transduction of physiological stimuli to energy production in the heart. Massive proliferation of mitochondria and promotion of mitochondrial respiration in cardiac myocytes in transgenic mice as a result of cardiac-specific overexpression of PGC-1 indicate that PGC-1 promotes mitochondrial biogenesis and is capable of ATP production (14). It is therefore conceivable that PGC-1 plays an important role in ATP production in the heart. In addition, PGC-1 has been shown to increase expression of the mitochondrial regulatory factors NRF-1 and NRF-2 (33), both of which are key transcriptional activators of nuclear genes encoding a range of mitochondrial enzymes. Studies have also shown that NRF-2 binds to the promoter region of nuclear genes required for mitochondrial function, including human {beta}-ATP synthase, rat COX IV, and rat Tfam (27, 28, 33). The present study demonstrated that the protein level of PGC-1, mRNA expression of NRF-2, and mRNA expression and mitochondrial protein levels of Tfam, COX IV, and {beta}-ATP synthase were significantly decreased after trauma-hemorrhage. However, E2 or flutamide treatment significantly attenuated the decrease in PGC-1, NRF-2, Tfam, COX IV, and {beta}-ATP synthase mRNA expression and protein levels under those conditions. In our studies, no significant change in expression of NRF-1 after trauma-hemorrhage (data not shown) suggests that the protective effects of E2 and flutamide on cardiac function after trauma-hemorrhage are related to NRF-2 and not to NRF-1. Thus it appears that a common mechanism is responsible for producing the salutary effects of E2 and flutamide after trauma-hemorrhage, i.e., upregulation of PGC-1 and related downstream signaling molecules in the heart with trauma-hemorrhage.

It is known that estrogen mediates its action via ER-{alpha} and ER-{beta} (20). Moreover, our previous studies showed that the salutary effects of E2 on cardiac function after trauma-hemorrhage can be abolished by administration of the specific ER antagonist ICI-182780 (11). Furthermore, our previous study also demonstrated that pretreatment with flutamide led to increased ER expression in T lymphocytes of sham-operated and trauma-hemorrhaged male rats (26). Indeed, we recently found that flutamide treatment upregulates ER-{alpha} and ER-{beta} expression in cardiomyocytes after trauma-hemorrhage (36). Furthermore, our findings suggesting that flutamide-mediated upregulation of PGC-1 was inhibited by ICI-182780 further support the notion that the salutary effects of flutamide on cardiac function after trauma-hemorrhage are due to upregulation of ER. These findings would thus suggest that the salutary effects of flutamide and E2 are mediated through upregulation of cardiac PGC-1 via ER after trauma-hemorrhage.

Studies have shown that PGC-1 mediates nitric oxide-induced mitochondrial biogenesis (19). Moreover, our previous study also showed that administration of L-arginine after trauma-hemorrhage restored cardiac function through increased production of nitric oxide with trauma-hemorrhage (1). Whether L-arginine also restores the depressed mitochondrial function after trauma-hemorrhage remains to be determined. Nonetheless, the results collectively suggest that E2- as well as flutamide-mediated PGC-1 upregulation after trauma-hemorrhage may be through nitric oxide. This, however, remains to be determined.

In summary, our results indicate that administration of E2 or flutamide after trauma-hemorrhage restored depressed cardiac function and normalized cardiac PGC-1 levels, mitochondrial ATP, cytochrome-c oxidase activity, and the mitochondrial DNA-encoded gene COX I. Moreover, E2 or flutamide treatment also increased NRF-2, Tfam, COX IV, and {beta}-ATP synthase expression. Furthermore, prevention of flutamide-mediated PGC-1 upregulation by treatment of trauma-hemorrhaged rats with ICI-182780 suggests that E2 and flutamide exert their beneficial effect via a common mechanism: ER-mediated upregulation of PGC-1.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by National Institute of General Medical Sciences Grant R37 GM-39519.


   FOOTNOTES
 

Address for reprint requests and other correspondence: I. H. Chaudry, Center for Surgical Research, Univ. of Alabama at Birmingham, 1670 Univ. Blvd., Volker Hall, Rm. G094, Birmingham, AL 35294-0019 (e-mail: Irshad.Chaudry{at}ccc.uab.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Angele MK, Smail N, Wang P, Cioffi WG, Bland KI, and Chaudry IH. L-Arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. Surgery 124: 394–401, 1998.[Web of Science][Medline]
  2. Ba ZF, Wang P, Koo DJ, Cioffi WG, Bland KI, and Chaudry IH. Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit Care Med 28: 2837–2842, 2000.[CrossRef][Web of Science][Medline]
  3. Ba ZF, Wang P, Koo DJ, Ornan DA, Bland KI, and Chaudry IH. Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock. Arch Surg 136: 1158–1163, 2001.[Abstract/Free Full Text]
  4. Chaudry IH. Cellular mechanisms in shock and ischemia and their correction. Am J Physiol Regul Integr Comp Physiol 245: R117–R134, 1983.[Abstract/Free Full Text]
  5. Cobb JP, Brownstein BH, Watson MA, Shannon WD, Laramie JM, Qiu Y, Stormo GD, Morrissey JJ, Buchman TG, Karl IE, and Hotchkiss RS. Injury in the era of genomics. Shock 15: 165–170, 2001.[Web of Science][Medline]
  6. Dong X, Ghoshal K, Majumder S, Yadav SP, and Jacob ST. Mitochondrial transcription factor A and its downstream targets are up-regulated in a rat hepatoma. J Biol Chem 277: 43309–43318, 2002.[Abstract/Free Full Text]
  7. Fantappie MR, Galina A, Luis de Mendonca R, Furtado DR, Secor WE, Colley DG, Correa-Oliveira R, Freeman G Jr, Tempone AJ, Lannes de Camargo L, and Rumjanek DF. Molecular characterization of a NADH ubiquinone oxidoreductase subunit 5 from Schistosoma mansoni and inhibition of mitochondrial respiratory chain function by testosterone. Mol Cell Biochem 202: 149–158, 1999.[Medline]
  8. Hauptman JG, DeJong GK, Blasko KA, and Chaudry IH. Measurement of hepatocellular function, cardiac output, effective blood volume, and oxygen saturation in rats. Am J Physiol Regul Integr Comp Physiol 257: R439–R444, 1989.[Abstract/Free Full Text]
  9. Hubbard WJ, Bland KI, and Chaudry IH. The role of the mitochondrion in trauma and shock. Shock 22: 395–402, 2004.[Medline]
  10. Jarrar D, Wang P, Cioffi WG, Bland KI, and Chaudry IH. The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol 279: H1015–H1021, 2000.[Abstract/Free Full Text]
  11. Jarrar D, Wang P, Knoferl MW, Kuebler JF, Cioffi WG, Bland KI, and Chaudry IH. Insight into the mechanism by which estradiol improves organ functions after trauma-hemorrhage. Surgery 128: 246–252, 2000.[CrossRef][Web of Science][Medline]
  12. Junger WG, Coimbra R, Liu FC, Herdon-Remelius C, Junger W, Junger H, Loomis W, Hoyt DB, and Altman A. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock 8: 235–241, 1997.[Web of Science][Medline]
  13. Kher A, Wang M, Tsai BM, Pitcher JM, Greenbaum ES, Nagy RD, Patel KM, Wairiuko GM, Markel TA, and Meldrum DR. Sex differences in the myocardial inflammatory response to acute injury. Shock 23: 1–10, 2005.[Web of Science][Medline]
  14. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, and Kelly DP. Peroxisome proliferator-activated receptor-{gamma} coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106: 847–856, 2000.[Web of Science][Medline]
  15. Masuda T, Sato K, Noda C, Ikeda KM, Matsunaga A, Ogura MN, Shimizu K, Nagasawa H, Matsuyama N, and Izumi T. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit Care Med 31: 1987–1992, 2003.[CrossRef][Medline]
  16. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, and Harken AH. Hemorrhage activates myocardial NF-{kappa}B and increases TNF-{alpha} in the heart. J Mol Cell Cardiol 29: 2849–2854, 1997.[CrossRef][Web of Science][Medline]
  17. Mendelsohn ME and Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583–1587, 2005.[Abstract/Free Full Text]
  18. Mizushima Y, Wang P, Jarrar D, Cioffi WG, Bland KI, and Chaudry IH. Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann Surg 232: 673–679, 2000.[CrossRef][Web of Science][Medline]
  19. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, and Carruba MO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299: 896–899, 2003.[Abstract/Free Full Text]
  20. Olefsky JM. Nuclear receptor minireview series. J Biol Chem 276: 36863–36864, 2001.[Free Full Text]
  21. Paxian M, Bauer I, Rensing H, Jaeschke H, Mautes AE, Kolb SA, Wolf B, Stockhausen A, Jeblick S, and Bauer M. Recovery of hepatocellular ATP and "pericentral apoptosis" after hemorrhage and resuscitation. FASEB J 17: 993–1002, 2003.[Abstract/Free Full Text]
  22. Puigserver P and Spiegelman BM. Peroxisome proliferator-activated receptor-{gamma} coactivator 1{alpha} (PGC-1{alpha}): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78–90, 2003.[Abstract/Free Full Text]
  23. Remmers DE, Cioffi WG, Bland KI, Wang P, Angele MK, and Chaudry IH. Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg 227: 790–799, 1998.[CrossRef][Web of Science][Medline]
  24. Remmers DE, Wang P, Cioffi WG, Bland KI, and Chaudry IH. Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol Heart Circ Physiol 273: H2919–H2925, 1997.[Abstract/Free Full Text]
  25. Ripple MO, Hagopian K, Oberley TD, Schatten H, and Weindruch R. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxid Redox Signal 1: 71–81, 1999.[Medline]
  26. Samy TS, Schwacha MG, Cioffi WG, Bland KI, and Chaudry IH. Androgen and estrogen receptors in splenic T lymphocytes: effects of flutamide and trauma-hemorrhage. Shock 14: 465–470, 2000.[Web of Science][Medline]
  27. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576: 1–14, 2002.[Medline]
  28. Scarpulla RC. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286: 81–89, 2002.[CrossRef][Web of Science][Medline]
  29. Toth B, Yokoyama Y, Kuebler JF, Schwacha MG, Rue LW III, Bland KI, and Chaudry IH. Sex differences in hepatic heme oxygenase expression and activity following trauma and hemorrhagic shock. Arch Surg 138: 1375–1382, 2003.[Abstract/Free Full Text]
  30. Wang J, Green PS, and Simpkins JW. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 77: 804–811, 2001.[CrossRef][Web of Science][Medline]
  31. Wichmann MW, Angele MK, Ayala A, Cioffi WG, and Chaudry IH. Flutamide: a novel agent for restoring the depressed cell-mediated immunity following soft-tissue trauma and hemorrhagic shock. Shock 8: 242–248, 1997.[Web of Science][Medline]
  32. Wu LL, Tang C, and Liu MS. Altered phosphorylation and calcium sensitivity of cardiac myofibrillar proteins during sepsis. Am J Physiol Regul Integr Comp Physiol 281: R408–R416, 2001.[Abstract/Free Full Text]
  33. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, and Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115–124, 1999.[CrossRef][Web of Science][Medline]
  34. Yang S, Zheng R, Hu S, Ma Y, Choudhry MA, Messina JL, Rue LW III, Bland KI, and Chaudry IH. Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function. Am J Physiol Heart Circ Physiol 287: H2183–H2191, 2004.[Abstract/Free Full Text]
  35. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, and Simpkins JW. Mitochondrial localization of estrogen receptor-{beta}. Proc Natl Acad Sci USA 101: 4130–4135, 2004.[Abstract/Free Full Text]
  36. Yu HP, Yang S, Choudhry MA, Hsieh YC, Bland KI, and Chaudry IH. Mechanism responsible for the salutary effects of flutamide on cardiac performance following trauma-hemorrhagic shock: upregulation of cardiomyocyte estrogen receptors. Surgery 138: 85–92, 2005.[CrossRef][Web of Science][Medline]
  37. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, and Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 279: H2766–H2775, 2000.[Abstract/Free Full Text]
  38. Zuckerbraun BS, McCloskey CA, Gallo D, Liu F, Ifedigbo E, Otterbein LE, and Billiar TR. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock 23: 527–532, 2005.[Web of Science][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W.-H. Kan, J.-T. Hsu, Z.-F. Ba, M. G. Schwacha, J. Chen, M. A. Choudhry, K. I. Bland, and I. H. Chaudry
p38 MAPK-dependent eNOS upregulation is critical for 17{beta}-estradiol-mediated cardioprotection following trauma-hemorrhage
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2627 - H2636.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J.-T. Hsu, Y.-C. Hsieh, W. H. Kan, J. G. Chen, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry
Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2982 - H2987.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Kawai, Y. Yokoyama, S. Kawai, S. Yokoyama, K. Oda, T. Nagasaka, M. Nagino, I. H. Chaudry, and Y. Nimura
Does estrogen contribute to the hepatic regeneration following portal branch ligation in rats?
Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G582 - G589.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
F. Hildebrand, W. J. Hubbard, M. A. Choudhry, B. M. Thobe, H.-C. Pape, and I. H. Chaudry
Effects of 17{beta}-estradiol and flutamide on inflammatory response and distant organ damage following trauma-hemorrhage in metestrus females
J. Leukoc. Biol., October 1, 2006; 80(4): 759 - 765.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y.-C. Hsieh, M. A. Choudhry, H.-P. Yu, T. Shimizu, S. Yang, T. Suzuki, J. Chen, K. I. Bland, and I. H. Chaudry
Inhibition of cardiac PGC-1{alpha} expression abolishes ER{beta} agonist-mediated cardioprotection following trauma-hemorrhage
FASEB J, June 1, 2006; 20(8): 1109 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-C. Hsieh, S. Yang, M. A. Choudhry, H.-P. Yu, K. I. Bland, M. G. Schwacha, and I. H. Chaudry
Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H416 - H423.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/H2665    most recent
00682.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, Y.-C.
Right arrow Articles by Chaudry, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, Y.-C.
Right arrow Articles by Chaudry, I. H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.